BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2875933)

  • 1. The molecular genetics of hyperlipidemia.
    Shoulders CC; Baralle FE
    Horiz Biochem Biophys; 1986; 8():299-340. PubMed ID: 2875933
    [No Abstract]   [Full Text] [Related]  

  • 2. Familial combined hyperlipidaemia linked to the apolipoprotein AI-CII-AIV gene cluster on chromosome 11q23-q24.
    Wojciechowski AP; Farrall M; Cullen P; Wilson TM; Bayliss JD; Farren B; Griffin BA; Caslake MJ; Packard CJ; Shepherd J
    Nature; 1991 Jan; 349(6305):161-4. PubMed ID: 1670899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haplotypes identified by DNA restriction-fragment-length polymorphisms in the A-1 C-III A-IV gene region and hypertriglyceridemia.
    Stocks J; Paul H; Galton D
    Am J Hum Genet; 1987 Aug; 41(2):106-18. PubMed ID: 2887109
    [No Abstract]   [Full Text] [Related]  

  • 4. The association between primary gout and hypertriglyceridaemia may be due to genetic linkage.
    Ferns GA; Lanham J; Galton DJ
    Monogr Atheroscler; 1985; 13():121-3. PubMed ID: 3937047
    [No Abstract]   [Full Text] [Related]  

  • 5. Cloning of apoprotein AI gene and observation on DNA polymorphism of apoprotein AI/CIII gene-loci in genomic library from a liver of Chinese.
    Xu HJ; Zhou HY; Hu SX; Pan XR
    Chin Med J (Engl); 1989 Mar; 102(3):169-73. PubMed ID: 2569382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA polymorphisms in and around the Apo-A1-CIII genes and genetic hyperlipidemias.
    Hayden MR; Kirk H; Clark C; Frohlich J; Rabkin S; McLeod R; Hewitt J
    Am J Hum Genet; 1987 May; 40(5):421-30. PubMed ID: 2883893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E (role in lipoprotein metabolism and pathophysiology of hyperlipoproteinemia type III).
    Utermann G
    Ric Clin Lab; 1982; 12(1):23-30. PubMed ID: 6283616
    [No Abstract]   [Full Text] [Related]  

  • 8. Genetics and molecular biology.
    Chamberlain JC
    Curr Opin Lipidol; 1997 Oct; 8(5):U63-4. PubMed ID: 9335960
    [No Abstract]   [Full Text] [Related]  

  • 9. A mouse model with features of familial combined hyperlipidemia.
    Masucci-Magoulas L; Goldberg IJ; Bisgaier CL; Serajuddin H; Francone OL; Breslow JL; Tall AR
    Science; 1997 Jan; 275(5298):391-4. PubMed ID: 8994037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein A-I/C-III/A-IV gene cluster in familial combined hyperlipidemia: effects on LDL-cholesterol and apolipoproteins B and C-III.
    Dallinga-Thie GM; Bu XD; van Linde-Sibenius Trip M; Rotter JI; Lusis AJ; de Bruin TW
    J Lipid Res; 1996 Jan; 37(1):136-47. PubMed ID: 8820109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance and familial dyslipidaemias.
    Ascaso JF; Real JT; Carmena R
    Diabetes Obes Metab; 1999 Nov; 1(6):323-30. PubMed ID: 11225648
    [No Abstract]   [Full Text] [Related]  

  • 12. Disorders of lipid transport: relationship to abnormalities of apoproteins, enzymes and cellular receptors.
    Schonfeld G
    Prog Clin Biol Res; 1984; 147():375-402. PubMed ID: 6330755
    [No Abstract]   [Full Text] [Related]  

  • 13. Apolipoprotein AI-CIII gene polymorphisms in Japanese myocardial infarction survivors.
    Satoh J; Hattori N; Onuki M; Yamakawa K; Fujiwara H; Amamiya H; Nagaoka H; Sakuma T; Yamanouchi Y; Okafuji T
    Jinrui Idengaku Zasshi; 1987 Mar; 32(1):15-20. PubMed ID: 2886684
    [No Abstract]   [Full Text] [Related]  

  • 14. A DNA polymorphism of the apoprotein AII gene in hypertriglyceridaemia.
    Ferns GA; Shelley CS; Stocks J; Rees A; Paul H; Baralle F; Galton DJ
    Hum Genet; 1986 Nov; 74(3):302-6. PubMed ID: 2877939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of familial hypercholesterolemia using DNA haplotype analysis in three large families with two hyperlipidemic parents.
    Schuster H; Keller C; Wolfram G; Zöllner N
    Ann Nutr Metab; 1992; 36(2):79-86. PubMed ID: 1354952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of polymorphisms in the apolipoprotein AI-CIII-AIV cluster to hyperlipidaemia in patients with gout.
    Cardona F; Tinahones FJ; Collantes E; Escudero A; García-Fuentes E; Soriguer FJ
    Ann Rheum Dis; 2005 Jan; 64(1):85-8. PubMed ID: 15115711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subclasses of low-density lipoprotein and very low-density lipoprotein in familial combined hyperlipidemia: relationship to multiple lipoprotein phenotype.
    Georgieva AM; van Greevenbroek MM; Krauss RM; Brouwers MC; Vermeulen VM; Robertus-Teunissen MG; van der Kallen CJ; de Bruin TW
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):744-9. PubMed ID: 14751815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variants of the lipoproteins and hyperlipidaemia.
    Galton DJ; Stocks J; Rees A
    Biochem Soc Trans; 1985 Feb; 13(1):31-4. PubMed ID: 3922820
    [No Abstract]   [Full Text] [Related]  

  • 19. Unusual xanthomas in a young patient with heterozygous familial hypercholesterolemia and type III hyperlipoproteinemia.
    Feussner G; Dobmeyer J; Nissen H; Hansen TS
    Am J Med Genet; 1996 Oct; 65(2):149-54. PubMed ID: 8911609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic basis for hypertriglyceridaemia in familial combined hyperlipidaemia.
    Erkelens DW
    Eur Heart J; 1998 Jul; 19 Suppl H():H23-6. PubMed ID: 9717061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.